Palliative care provision for children in general practice: A retrospective cohort study

Marijanne Engel1, Matthew P Grant1, Anna Kleiboer2

  • 1Julius Center for Health Sciences and Primary Care, Department of General Practice and Nursing Science, Center of Expertise in Palliative Care Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Insights

General practitioners (GPs) are highly involved in pediatric palliative care, with most children having GP contact in their last 3 months of life. However, palliative status and advance care planning are not routinely documented.

Area of Science:

  • Pediatric Palliative Care
  • General Practice Medicine
  • Healthcare Utilization

Background:

  • Annually, approximately 750 children (0-21 years) in the Netherlands die from conditions requiring palliative care.
  • Most of these children receive care at home, supported by hospital services and primary care providers.

Purpose of the Study:

  • To investigate the utilization of general practice services for pediatric palliative care patients in the final two years of life.
  • To analyze the frequency and nature of general practitioner (GP) consultations for children nearing the end of life.

Main Methods:

  • A retrospective cohort study utilizing the Julius General Practitioners' Network healthcare database.
  • Inclusion criteria: children (0-21 years) deceased between 2013-2022 from a chronic condition.
  • Outcome measured: number of GP consultations in the last 3 months of life, comparing children who died at home versus in hospital.

Main Results:

  • Forty-eight children from 32 GP practices were analyzed; common diagnoses included oncological, congenital, and metabolic conditions.
  • Ninety-six percent of children had GP contact in the last 3 months (median 7 consultations).
  • Children dying at home had significantly more GP consultations (median 9.5) than those dying in hospital (median 3.5; p < 0.001).

Conclusions:

  • General practitioners play a significant role in providing pediatric palliative care.
  • The palliative nature of care and advance care planning discussions are not consistently documented by GPs.
  • Further guidance is needed to support GPs in collaboration with other professionals for home-based pediatric palliative care.
Abstract

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...